Literature DB >> 24966602

Pathogenesis of liver cirrhosis.

Wen-Ce Zhou1, Quan-Bao Zhang1, Liang Qiao1.   

Abstract

Liver cirrhosis is the final pathological result of various chronic liver diseases, and fibrosis is the precursor of cirrhosis. Many types of cells, cytokines and miRNAs are involved in the initiation and progression of liver fibrosis and cirrhosis. Activation of hepatic stellate cells (HSCs) is a pivotal event in fibrosis. Defenestration and capillarization of liver sinusoidal endothelial cells are major contributing factors to hepatic dysfunction in liver cirrhosis. Activated Kupffer cells destroy hepatocytes and stimulate the activation of HSCs. Repeated cycles of apoptosis and regeneration of hepatocytes contribute to pathogenesis of cirrhosis. At the molecular level, many cytokines are involved in mediation of signaling pathways that regulate activation of HSCs and fibrogenesis. Recently, miRNAs as a post-transcriptional regulator have been found to play a key role in fibrosis and cirrhosis. Robust animal models of liver fibrosis and cirrhosis, as well as the recently identified critical cellular and molecular factors involved in the development of liver fibrosis and cirrhosis will facilitate the development of more effective therapeutic approaches for these conditions.

Entities:  

Keywords:  Animal model; Cirrhosis; Cytokine; Hepatic stellate cells; Pathogenesis; Therapy; miRNA

Mesh:

Substances:

Year:  2014        PMID: 24966602      PMCID: PMC4064077          DOI: 10.3748/wjg.v20.i23.7312

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  199 in total

1.  Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.

Authors:  Toni Urbanik; Regina Johanna Boger; Thomas Longerich; Katharina Becker; Karl Roland Ehrenberg; Nadine Hövelmeyer; Matthias Hahn; Marcus Schuchmann; Dirk Jäger; Ari Waisman; Marcus Alexander Wörns; Henning Schulze-Bergkamen
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

2.  Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats.

Authors:  Dan Xu; Yong Wu; Zhang-Xiu Liao; Hui Wang
Journal:  Pharmacol Res       Date:  2006-12-19       Impact factor: 7.658

Review 3.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

4.  Vitamin E reduces hepatic fibrosis in mice with Schistosoma japonicum infection.

Authors:  Xuefeng Wang; Rongbo Zhang; Jiuwei Du; Youying Hu; Lifa Xu; Jun Lu; Song Ye
Journal:  Mol Med Rep       Date:  2011-11-01       Impact factor: 2.952

5.  Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease.

Authors:  G Tarantino; A Colao; D Capone; P Conca; M Tarantino; E Grimaldi; D Chianese; C Finelli; F Contaldo; F Scopacasa; S Savastano
Journal:  J Biol Regul Homeost Agents       Date:  2011 Jan-Mar       Impact factor: 1.711

6.  Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats.

Authors:  J Y Wang; J S Guo; H Li; S L Liu; M A Zern
Journal:  Liver       Date:  1998-06

7.  Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells.

Authors:  Stefanos Klironomos; George Notas; Ourania Sfakianaki; Foteini Kiagiadaki; Costas Xidakis; Elias Kouroumalis
Journal:  Regul Pept       Date:  2013-11-26

8.  Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.

Authors:  Michio Hara; Hiroshi Kono; Shinji Furuya; Kazuyoshi Hirayama; Masato Tsuchiya; Hideki Fujii
Journal:  J Surg Res       Date:  2013-03-28       Impact factor: 2.192

Review 9.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.

Authors:  Wen-Jun Du; Jun-Hui Zhen; Zhao-Qing Zeng; Zhao-Min Zheng; Yan Xu; Lai-Ying Qin; Shi-Jun Chen
Journal:  Diagn Pathol       Date:  2013-02-28       Impact factor: 2.644

View more
  136 in total

Review 1.  [Modern magnetic resonance imaging of the liver].

Authors:  D M Hedderich; K Weiss; D Maintz; T Persigehl
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

2.  An integrative method to predict signalling perturbations for cellular transitions.

Authors:  Gaia Zaffaroni; Satoshi Okawa; Manuel Morales-Ruiz; Antonio Del Sol
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

Review 3.  Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.

Authors:  Jing-Si Wang; Qiu-Yun Zhang; Jin-Lian Cheng; Lan-Yu Chen; Nai-Li Yao; Gui-Zhi Sun; Yu-Ling Chu
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978

4.  Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury.

Authors:  Wen-Ju Chang; Lu-Jun Song; Tuo Yi; Kun-Tang Shen; Hong-Shan Wang; Xiao-Dong Gao; Min Li; Jian-Min Xu; Wei-Xin Niu; Xin-Yu Qin
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  Anti-fibrotic Effects and Mechanism of Shengmai Injection () on Human Hepatic Stellate Cells LX-2.

Authors:  Yi Zhang; Li-Tian Ma; Jie Li; Yu Qiao; Jun-Ye Liu; Jin Wang; Qin-You Ren; Jin-Tao Hu; Jin Zheng
Journal:  Chin J Integr Med       Date:  2018-11-22       Impact factor: 1.978

6.  Hepatic Encephalopathy in Liver Cirrhosis.

Authors:  Herbert Djiambou-Nganjeu
Journal:  J Transl Int Med       Date:  2017-03-31

Review 7.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

8.  Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway.

Authors:  Yu-Rong Wang; Ru-Tao Hong; Yuan-Yuan Xie; Jian-Ming Xu
Journal:  Curr Med Sci       Date:  2018-04-30

9.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

Review 10.  Thrombin activation and liver inflammation in advanced hepatitis C virus infection.

Authors:  Emilio González-Reimers; Geraldine Quintero-Platt; Candelaria Martín-González; Onán Pérez-Hernández; Lucía Romero-Acevedo; Francisco Santolaria-Fernández
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.